ACM
Arlington Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,810
| Closed | -$2.8M | – | 98 |
|
|
2023
Q1 | $2.8M | Buy |
28,810
+17,693
| +159% | +$1.72M | 2.63% | 11 |
|
|
2022
Q4 | $1.15M | Buy |
+11,117
| New | +$1.15M | 1.29% | 24 |
|
|
2015
Q3 | – | Sell |
-50,369
| Closed | -$6.98M | – | 19 |
|
|
2015
Q2 | $6.98M | Buy |
50,369
+5,380
| +12% | +$745K | 4.67% | 9 |
|
|
2015
Q1 | $5.61M | Buy |
44,989
+18,550
| +70% | +$2.31M | 4.02% | 9 |
|
|
2014
Q4 | $2.39M | Buy |
+26,439
| New | +$2.39M | 2.02% | 15 |
|